Search results for "Cilazapril"

showing 3 items of 3 documents

Effects of cilazapril on renal haemodynamics and function in hypertensive patients: a randomised controlled study versus hydrochlorothiazide.

1995

In this study the efficacy and safety of short-term cilazapril administration on renal haemodynamics were evaluated in mild to moderate hypertensive subjects. Our final goal was to evaluate whether the reduction in blood pressure achieved by treatment was associated with maintained renal function. After a run-in period with placebo, 40 hypertensive subjects without renal or cardiac diseases were randomly allocated to a double-blind 4 week controlled trial with cilazapril 5 mg once a day (20 patients) or hydrochlorothiazide 25 mg once a day (20 patients). Renal haemodynamics measurements included effective renal plasma flow (ERPF) and glomerular filtration rate (GFR) by radionuclide study us…

AdultMalemedicine.medical_specialtySettore MED/09 - Medicina InternaUrologyRenal functionAngiotensin-Converting Enzyme InhibitorsCilazaprilEssential hypertensionRenal CirculationHydrochlorothiazideDouble-Blind MethodInternal medicineInternal MedicinemedicineAngiotensin-Converting Enzyme InhibitorsAntihypertensive Agents Hydrochlorothiazide CilazaprilHumansAntihypertensive AgentsAgedRenal circulationbusiness.industryHemodynamicsGeneral MedicineEffective renal plasma flowCilazaprilMiddle Agedmedicine.diseaseSettore MED/45 - Scienze Infermieristiche Generali Cliniche E PediatricheSettore MED/11 - Malattie Dell'Apparato CardiovascolareFiltration fractionmedicine.anatomical_structureEndocrinologyHydrochlorothiazideTreatment OutcomeRenal blood flowHypertensionSettore BIO/14 - FarmacologiaFemaleCardiology and Cardiovascular Medicinebusinessmedicine.drugGlomerular Filtration RateBlood pressure
researchProduct

Verlaufsbeobachtung von Patienten mit chronischer Aortenklappeninsuffizienz unter ACE-Hemmer-Therapie (Follow-up of patients with chronic severe aort…

1997

In dieser Untersuchung wurde der Einflus einer 3monatigen ACE-Hemmer-Therapie mit Cilazapril (2,5–5 mg) bei 13 Patienten mit chronischer Aortenklappeninsuffizienz spiroergometrisch und echokardiographisch untersucht. Nach 3monatiger Therapie sanken der linksventrikulare enddiastolische Diameter-Index von 3,5 auf 3,1 cm/m2 (p = 0,005), der linksventrikulare endsystolische Diameter-Index von 2,3 auf 2,0 cm/m2 (p = 0,005). Der Wallstress reduzierte sich von 174 auf 150 dyn/cm2 (p = 0,01). Die linksventrikulare Muskelmasse nahm um 14% ab, von anfangs 570 g (= 295 g/m2) auf 488 g (= 253 g/m2) (p < 0,05). Die von apikal gemesesene Jetflache reduzierte sich von 10,1 auf 8,1 cm2 (p < 0,05). Weder d…

Gynecologymedicine.medical_specialtyInsuficiencia aorticabiologybusiness.industryPeptidyl-Dipeptidase AFollow up studiesAngiotensin-converting enzymeCilazaprilValvula aorticamedicinebiology.proteinCardiology and Cardiovascular Medicinebusinessmedicine.drugZeitschrift f�r Kardiologie
researchProduct

Exercise performance in hypertensives: felodipine vs cilazapril cross-over study

1999

medicine.medical_specialtyFelodipinebusiness.industryInternal medicineExercise performanceInternal MedicineCardiologyMedicineCilazaprilbusinessCrossover studymedicine.drugAmerican Journal of Hypertension
researchProduct